There were 1,446 press releases posted in the last 24 hours and 427,446 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Communiqué de presse : La FDA accorde un examen prioritaire à la demande de licence supplémentaire relative au Dupixent pour le traitement ciblé de la pemphigoïde bulleuse

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image